| Literature DB >> 29670664 |
Yulin Zhang1, Maoxian Zhao1, Jionglong Su2, Xiao Lu3, Kebo Lv4.
Abstract
A novel model for cascading failures in a directed logic network based on the degree strength at a node was proposed. The definitions of in-degree and out-degree strength of a node were initially reconsidered, and the load at a nonisolated node was proposed as the ratio of in-degree strength to out-degree strength of the node. The cascading failure model based on degree strength was applied to the logic network for three types of cancer including adenocarcinoma of lung, prostate cancer, and colon cancer based on their gene expression profiles. In order to highlight the differences between the three networks by the cascading failure mechanism, we used the largest-scale cascades and the cumulative cascade probability to depict the damage. It was found that the cascading failures caused by hubs are usually larger. Furthermore, the result shows that propagations against the networks were correlated with the structures motifs of connected logical doublets. Finally, some genes were selected based on cascading failure mechanism. We believe that these genes may be involved in the occurrence and development of three types of cancer.Entities:
Mesh:
Year: 2018 PMID: 29670664 PMCID: PMC5836303 DOI: 10.1155/2018/8950794
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
Figure 1In-degrees and out-degrees for node i of all 1st-order logical relationships.
Figure 2In-degree and out-degree for node i by some 2nd-order logical relationships.
Definition of in-degree and out-degree of 2nd-order logic.
| Logic type | Out-degree of | Out-degree of | In-degree of |
|---|---|---|---|
|
| 1/4 | 1/2 | 1/2 |
|
| 3/4 | 3/4 | 3/2 |
|
| 3/4 | 3/4 | 3/2 |
|
| 1/4 | 1/4 | 1/2 |
|
| 1/4 | 1/4 | 1/2 |
|
| 1/4 | 1/4 | 1/2 |
|
| 3/4 | 3/4 | 3/2 |
|
| 3/4 | 3/4 | 3/2 |
|
| 1/2 | 1/2 | 1 |
|
| 1/2 | 1/2 | 1 |
Detailed list of data source.
| Type | Group | Platform | Database | Value type | Sample size |
|---|---|---|---|---|---|
| Adenocarcinoma of lung | Control group I | GPL96 | GSE12667 | Value, | 73 |
| Experimental group I | 68 | ||||
|
| |||||
| Prostate cancer | Control group II | GPL8300 | GSE6919 | Value, | 50 |
| Experimental group II | 43 | ||||
|
| |||||
| Colon cancer | Control group III | GPL570 | GDS3630 | Value, | 40 |
| Experimental group III | GSE2109 | 39 | |||
Network structure features for different cancer with change of thresholds.
| Types | Thresholds | Number of nodes | Number of edges | Number of 1st logic types | Number of 2nd logic types | Average degree |
|---|---|---|---|---|---|---|
| Adenocarcinoma of lung | (0.15,0.30) | 60 | 1008 | 92 | 916 | 25.21 |
| (0.20,0.35) | 60 | 332 | 60 | 272 | 9.56 | |
| (0.25,0.40) | 60 | 297 | 42 | 255 | 7.60 | |
| (0.30,0.45) | 60 | 112 | 18 | 94 | 4.75 | |
|
| ||||||
| Prostate cancer | (0.15,0.30) | 65 | 773 | 68 | 705 | 20.2 |
| (0.20,0.35) | 65 | 255 | 29 | 226 | 6.71 | |
| (0.25,0.40) | 65 | 109 | 13 | 96 | 4.11 | |
| (0.30,0.45) | 65 | 50 | 12 | 38 | 3.28 | |
|
| ||||||
| Colon cancer | (0.15,0.30) | 79 | 2543 | 94 | 2499 | 34.05 |
| (0.20,0.35) | 79 | 1301 | 40 | 1261 | 32.23 | |
| (0.25,0.40) | 79 | 549 | 24 | 525 | 13.13 | |
| (0.30,0.45) | 79 | 324 | 15 | 309 | 7.77 | |
Figure 3The change curves of the largest size ratio of cascading failure with increasing of capacity parameter.
Figure 4Plots of P(d′ ≥ d) versus d for gene networks with types of cancer under some thresholds.
Degrees and Rmax of some gene nodes in logical networks with three types of cancer under all the thresholds.
| Threshold | RBL1 | MAPK9 | PIK3CA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (0.15,0.30) | 35% | 165 | 44.75 | 25% | 185.5 | 12 | 23.33% | 58 | 9.5 |
| (0.20,0.35) | 31.7% | 111 | 53.75 | 25% | 74 | 31.75 | 20% | 39 | 6.5 |
| (0.25,0.40) | 30% | 63.5 | 22 | 16.7% | 42.5 | 17.25 | 16.7% | 34.5 | 5.5 |
| (0.30,0.45) | 15% | 44 | 11.25 | 10% | 26.5 | 8.75 | 8.33% | 18 | 10.25 |
|
| |||||||||
| Threshold | CDH1 | MYC | SOS2 | ||||||
|
| |||||||||
| (0.15,0.30) | 64.61% | 125 | 35.5 | 50.77% | 104 | 25.5 | 30.77% | 76 | 31.25 |
| (0.20,0.35) | 50.70% | 62 | 16.75 | 21.53% | 58 | 10 | 16.92% | 43 | 11.25 |
| (0.25,0.40) | 26.15% | 16 | 7.75 | 18.46% | 14 | 7.75 | 13.84% | 12 | 6.5 |
| (0.30,0.45) | 12.31% | 13 | 3.25 | 9.23% | 8 | 5.25 | 9.23% | 7 | 3.75 |
|
| |||||||||
| Threshold | CDKN1A | TOP2A | REL | ||||||
|
| |||||||||
| (0.15,0.30) | 23.08% | 49.5 | 17.5 | 88.6% | 1239 | 22.75 | 32.91% | 163 | 11.5 |
| (0.20,0.35) | 15.38% | 26.5 | 14.25 | 53.16% | 123.5 | 27.75 | 48.10% | 60 | 45 |
| (0.25,0.40) | 15.38% | 6.5 | 8.75 | 20.25% | 41.5 | 14.75 | 20.25% | 42.5 | 12.25 |
| (0.30,0.45) | 7.69% | 5 | 2 | 13.92% | 34.5 | 13.5 | 13.92% | 31.5 | 9.5 |
|
| |||||||||
| Threshold | SHH | CHEK2 | ROS1 | ||||||
|
| |||||||||
| (0.15,0.30) | 27.84% | 89.5 | 41 | 27.84% | 140.5 | 17 | 25.31% | 69 | 14.5 |
| (0.20,0.35) | 45.57% | 69 | 30.25 | 45.57% | 68.5 | 27.5 | 25.32% | 46.5 | 21.75 |
| (0.25,0.40) | 18.99% | 41 | 4.75 | 13.92% | 16 | 19.5 | 12.66% | 16.5 | 8.75 |
| (0.30,0.45) | 11.39% | 16.5 | 9.75 | 11.39% | 13.5 | 5.75 | 7.59% | 11.5 | 3.75 |
Figure 5Six types of logic motif structures centered on node i.
Gene annotations selected by D-SCFM.
| Gene | Probe ID | Gene annotation | |
|---|---|---|---|
| (1) | RBL1 | 1555003_at | Human RB transcriptional corepressor like 1 |
| (2) | MAPK9 | 203218_at | Human mitogen-activated protein kinase 9 |
| (3) | PIK3CA | 204369_at | Human phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| (4) | CDH1 | 201130_s_at | Human cadherin 1 and related to the regulation of cell division |
| (5) | MYC | 202431_s_at | Human v-myc avian myelocytomatosis viral oncogene homolog |
| (6) | SOS2 | 211665_s_at | Human SOS Ras/Rho guanine nucleotide exchange factor 2 |
| (7) | CDKN1A | 1555186_at | Human encoding an effective cyclin dependent kinase inhibitor |
| (8) | TOP2A | 201292_at | Human topoisomerase (DNA) II alpha |
| (9) | REL | 206035_at | Human REL proto-oncogene, NF-kB subunit |
| (10) | SHH | 207586_at | Human sonic hedgehog and encoding SHH protein |
| (11) | CHEK2 | 210416_s_at | Human checkpoint kinase-2 |
| (12) | ROS1 | 244363_at | Human ROS proto-oncogene 1, receptor tyrosine kinase |